Review



endopredict (ep) sividon  (Sividon Diagnostics GmbH)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Sividon Diagnostics GmbH endopredict (ep) sividon
    Endopredict (Ep) Sividon, supplied by Sividon Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict+(ep)+sividon/endopredict++ep++sividon/pm25848913-143-1-3
    Average 90 stars, based on 1 article reviews
    endopredict (ep) sividon - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer
    Article Snippet: EndoPredict® (12-EP) , qRT-PCR (8 genes and 4 RNA/DNA reference genes) , Sividon, Koln, Germany , GEICAM 9906 (2014) ABCSG-34 (2020) UCBG 2–14 (2020) , ABCSG 6/ABCSG 8 (2011, 2013) , GEICAM 9906 (2014) , NCCN, ASCO, AGO, ESMO, St. Gallen, AJCC, EGTM, NICE.

    Article Title: Markers for the identification of late breast cancer recurrence.
    Article Snippet: The EndoPredict (EP) (Sividon, Cologne, Germany) has been developed for women with HR-positive/HER2negative disease and includes information of eight cancerrelated and three normalization genes [40].

    Article Title: The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer.
    Article Snippet: 12-Gene Assay (EndoPredict®, EP) EndoPredict® (Sividon Diagnostics GmbH) is a successor to ODx; it is a second-generation molecular assay that has shown significantly superior to ODx in analyses.

    Article Title: Markers for the identification of late breast cancer recurrence
    Article Snippet: The EndoPredict (EP) (Sividon, Cologne, Germany) has been developed for women with HR-positive/HER2-negative disease and includes information of eight cancer-related and three normalization genes [ ].

    Biomarker Discovery:

    Article Title: Developing a new generation of breast cancer clinical gene expression tests.
    Article Snippet: .. In the previous issue, Martin and colleagues describe the third clinical validation of EndoPredict (EP; Sividon Diagnostics GmbH, Cologne, Germany) [1], a secondgeneration multigene test trained to predict distant recurrence in ER+/HER2− tumors, and by extension the need for adjuvant chemotherapy. ..

    Article Title: Developing a new generation of breast cancer clinical gene expression tests.
    Article Snippet: .. In the previous issue, Martin and colleagues describe the third clinical validation of EndoPredict (EP; Sividon Diagnostics GmbH, Cologne, Germany) [1], a secondgeneration multigene test trained to predict distant recurrence in ER/HER2 tumors, and by extension the need for adjuvant chemotherapy. ..

    Adjuvant:

    Article Title: Developing a new generation of breast cancer clinical gene expression tests.
    Article Snippet: .. In the previous issue, Martin and colleagues describe the third clinical validation of EndoPredict (EP; Sividon Diagnostics GmbH, Cologne, Germany) [1], a secondgeneration multigene test trained to predict distant recurrence in ER+/HER2− tumors, and by extension the need for adjuvant chemotherapy. ..

    Article Title: Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer
    Article Snippet: .. More recently developed, the EndoPredict assay (EP) (Sividon Diagnostics GmbH, Cologne, Germany), is a test based on gene expression data in combination with two clinicopathological risk parameters (tumor and nodal status) to assess the risk of distant metastasis in patients with ER+/HER2- primary breast cancer if treated with adjuvant endocrine therapy alone [ ]. ..

    Article Title: Developing a new generation of breast cancer clinical gene expression tests.
    Article Snippet: .. In the previous issue, Martin and colleagues describe the third clinical validation of EndoPredict (EP; Sividon Diagnostics GmbH, Cologne, Germany) [1], a secondgeneration multigene test trained to predict distant recurrence in ER/HER2 tumors, and by extension the need for adjuvant chemotherapy. ..

    Endopredict Assay:

    Article Title: Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer
    Article Snippet: .. More recently developed, the EndoPredict assay (EP) (Sividon Diagnostics GmbH, Cologne, Germany), is a test based on gene expression data in combination with two clinicopathological risk parameters (tumor and nodal status) to assess the risk of distant metastasis in patients with ER+/HER2- primary breast cancer if treated with adjuvant endocrine therapy alone [ ]. ..

    Gene Expression:

    Article Title: Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer
    Article Snippet: .. More recently developed, the EndoPredict assay (EP) (Sividon Diagnostics GmbH, Cologne, Germany), is a test based on gene expression data in combination with two clinicopathological risk parameters (tumor and nodal status) to assess the risk of distant metastasis in patients with ER+/HER2- primary breast cancer if treated with adjuvant endocrine therapy alone [ ]. ..



    Similar Products

    endopredict (ep) sividon  (Sividon Diagnostics GmbH)
    90
    Sividon Diagnostics GmbH endopredict (ep) sividon
    Endopredict (Ep) Sividon, supplied by Sividon Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict+(ep)+sividon/endopredict++ep++sividon/pm25848913-143-1-3
    Average 90 stars, based on 1 article reviews
    endopredict (ep) sividon - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results